国家医保药品目录价格谈判对中国肺癌靶向药物定价、市场渗透和支出的影响
王成, 易洪彬, 韩晟, 史录文
Effects of NRDL price negotiations on the pricing, market penetration, and spending of targeted lung cancer medications in China
Cheng Wang, Hongbin Yi, Sheng Han, Luwen Shi
中国药学(英文版)
.
2025, (6): 543
-555
.
DOI: 10.5246/jcps.2025.06.041
>
>